The PDF file you selected should load here if your Web browser has a PDF reader plug-in installed (for example, a recent version of Adobe Acrobat Reader).

If you would like more information about how to print, save, and work with PDFs, Highwire Press provides a helpful Frequently Asked Questions about PDFs.

Alternatively, you can download the PDF file directly to your computer, from where it can be opened using a PDF reader. To download the PDF, click the Download link above.

Fullscreen Fullscreen Off

Introduction: Due to high variability of resistance patterns which vary even over short periods of time, periodic evaluation of such activity is essential. Aim: To document the prevalence, antibiotic susceptibility and resistance patterns of uropathogens in the area to ensure appropriate therapy. Methods: This is a cross sectional study on 5108 urine samples from June 2014 to May 2015. Antibiotic susceptibility testing was done by Kirby-Bauer disc diffusion method and compared. Gram positive cocci and Gram negative bacilli detected were further subjected to detection of Methicillin resistant Staphyloccocussureus (MRSA) by Cefoxitin disc diffusion tests and detection of Extended Spectrum Beta lactamases (ESBL) by ESBL screening test and confirmed by combined disc diffusion test(CDT). Results: Out of 5108 samples subjected to bacterial culture, 2940(57.56%) showed positive growth out of which Escherichia coli, 1300(44.2%) was the most common organism isolated followed by Staphylococcus aureus 914(31%), Klebsiella pneumonia 362(12.3%), Enterococcus 172(5.85%), Acinetobacter 80(2.72%), Pseudomonas 72(2.44%), Proteus 40(0.81%), and Staphylococcus saprophyticus 16(0.54%). On further evaluation, 1026(56.06%) isolates of Gram negative bacilli(GNB) family showed presence of ESBL and 722(78.99%) isolates of Staphylococcus aureus were positive for (MRSA) tests. Conclusion: Continual surveillance is required to detect changes in prevalence rates of different uropathogens. Increased prevalence of Acinetobacter was detected in our study. Monitoring of MRSA, ESBL production and antimicrobial susceptibility testing (AST) is necessary to avoid treatment failure and development of further resistance in patients with UTI.


Urinary Tract Infection, Acinetobacter.
Font Size